Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Quest Diagnostics CFO Robert Hagemann To Step Down At End Of May

RELATED NEWS
Trade DGX now with 

Medical testing services provider Quest Diagnostics, Inc. (DGX: Quote) announced Thursday that Senior Vice President and Chief Financial Officer Robert Hagemann plans to leave the company on May 31, 2013. He may leave earlier if a successor is named and the transition is complete before the end of May.

"We are grateful to Bob for his service to Quest Diagnostics and the leadership he has demonstrated since joining the company in 1992. Quest Diagnostics has benefited enormously from Bob's financial and business expertise over his long tenure with the company," President and CEO Steve Rusckowski said in a statement.

The Madison, New Jersey-based company said it is launching a search for a new CFO that will consider both internal and external candidates, with Hagemann assisting in identifying his successor.

Hagemann, who had a 21 career with the company, has been serving as CFO for the past fifteen years since August 1998. He joined Corning Life Sciences, Inc. in 1992, and came to Quest Diagnostics after it was spun-off from corning in 1996.

After holding various senior financial positions in Corning Life Sciences from 1992, Hagemann was named vice president and corporate controller of the company in 1996.

Prior to joining Corning Life Sciences in 1992, Hagemann was employed by Prime Hospitality, Inc. and Crompton & Knowles, Inc. in senior financial positions. He was also previously associated with Ernst & Young.

"At this point, after 21 years with the company and almost 15 years as the CFO, we agreed now is a good time for a change. I thank everyone at Quest for the tremendous support I have received over the years," Hagemann noted.

DGX closed Wednesday's regular trading session at $55.99, down $0.28 on a volume of 0.90 million shares.

Register
To receive FREE breaking news email alerts for Quest Diagnostics and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.